Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |